TY - JOUR
T1 - Janus magnetic cellular spheroids for vascular tissue engineering
AU - Mattix, Brandon M.
AU - Olsen, Timothy R.
AU - Casco, Megan
AU - Reese, Laura
AU - Poole, John T.
AU - Zhang, Jing
AU - Visconti, Richard P.
AU - Simionescu, Agneta
AU - Simionescu, Dan T.
AU - Alexis, Frank
N1 - Funding Information:
This work was supported by the American Heart Association Beginning Grant in Aid-2BGIA11720004 award to F.A., the SC EPSCoR Grant for Exploratory Academic Research-2012001188 award to F.A., and the NSF/EPSCOR EPS-0447660 award to R.P.V. The authors wish to thank Dr. R. Markwald from the Medical University of South Carolina and Dr. V. Mironov for discussing challenges and innovations in tissue fabrication. We would also like to thank Dr. T. Bruce and the Clemson Light Imaging Facility at Clemson University for technical support with microscopy and Mrs. L. Jenkins for her help with histological techniques.
PY - 2014/1
Y1 - 2014/1
N2 - Cell aggregates, or spheroids, have been used as building blocks to fabricate scaffold-free tissues that can closely mimic the native three-dimensional invivo environment for broad applications including regenerative medicine and high throughput testing of drugs. The incorporation of magnetic nanoparticles (MNPs) into spheroids permits the manipulation of spheroids into desired shapes, patterns, and tissues using magnetic forces. Current strategies incorporating MNPs often involve cellular uptake, and should therefore be avoided because it induces adverse effects on cell activity, viability, and phenotype. Here, we report a Janus structure of magnetic cellular spheroids (JMCS) with spatial control of MNPs to form two distinct domains: cells and extracellular MNPs. This separation of cells and MNPs within magnetic cellular spheroids was successfully incorporated into cellular spheroids with various cellular and extracellular compositions and contents. The amount of cells that internalized MNPs was quantified and showed that JMCSs resulted in significantly lower internalization (35%) compared to uptake spheroids (83%, p<0.05). Furthermore, the addition of MNPs to cellular spheroids using the Janus method has no adverse effects on cellular viability up to seven weeks, with spheroids maintaining at least 82% viability over 7 weeks when compared to control spheroids without MNPs. By safely incorporating MNPs into cellular spheroids, results demonstrated that JMCSs were capable of magnetic manipulation, and that magnetic forces used during magnetic force assembly mediate fusion into controlled patterns and complex tissues. Finally, JMCSs were assembled and fused into a vascular tissue construct 5mm in diameter using magnetic force assembly.
AB - Cell aggregates, or spheroids, have been used as building blocks to fabricate scaffold-free tissues that can closely mimic the native three-dimensional invivo environment for broad applications including regenerative medicine and high throughput testing of drugs. The incorporation of magnetic nanoparticles (MNPs) into spheroids permits the manipulation of spheroids into desired shapes, patterns, and tissues using magnetic forces. Current strategies incorporating MNPs often involve cellular uptake, and should therefore be avoided because it induces adverse effects on cell activity, viability, and phenotype. Here, we report a Janus structure of magnetic cellular spheroids (JMCS) with spatial control of MNPs to form two distinct domains: cells and extracellular MNPs. This separation of cells and MNPs within magnetic cellular spheroids was successfully incorporated into cellular spheroids with various cellular and extracellular compositions and contents. The amount of cells that internalized MNPs was quantified and showed that JMCSs resulted in significantly lower internalization (35%) compared to uptake spheroids (83%, p<0.05). Furthermore, the addition of MNPs to cellular spheroids using the Janus method has no adverse effects on cellular viability up to seven weeks, with spheroids maintaining at least 82% viability over 7 weeks when compared to control spheroids without MNPs. By safely incorporating MNPs into cellular spheroids, results demonstrated that JMCSs were capable of magnetic manipulation, and that magnetic forces used during magnetic force assembly mediate fusion into controlled patterns and complex tissues. Finally, JMCSs were assembled and fused into a vascular tissue construct 5mm in diameter using magnetic force assembly.
KW - Iron oxide
KW - Magnetic nanoparticles
KW - Spheroids
KW - Tissue engineering
KW - Tissue fusion
UR - http://www.scopus.com/inward/record.url?scp=84887624074&partnerID=8YFLogxK
U2 - 10.1016/j.biomaterials.2013.10.036
DO - 10.1016/j.biomaterials.2013.10.036
M3 - Artículo
C2 - 24183699
AN - SCOPUS:84887624074
SN - 0142-9612
VL - 35
SP - 949
EP - 960
JO - Biomaterials
JF - Biomaterials
IS - 3
ER -